| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/30/2002 | WO2001083561A3 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 05/30/2002 | WO2001073030A3 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells |
| 05/30/2002 | WO2001066776A3 Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
| 05/30/2002 | WO2001041741A9 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 05/30/2002 | WO2001040264A9 Peptide antigens |
| 05/30/2002 | WO2001039799A9 Passive desensitization |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020065407 Nucleotide sequences coding preferential polypeptide for use in the immunization of animal against viral diseases |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065396 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065241 A recombinant polynucleotide of first polynucleotides coding an antigenic peptide and are operatively linked to each other to enhance translation of the polynucleotides to the peptides and binding to MHC; cancer vaccine |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065218 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064872 Polypeptide for use in the detection and prevention of tumors; antitumor agents; anticarcinogenic agents |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064815 Ovarian tumor antigen and methods of use therefor |
| 05/30/2002 | US20020064803 Novel antibody compositions for preparing enriched eosinophil preparations |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064785 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064533 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 05/30/2002 | US20020064532 Virus mutant of given nucleotide sequence; vaccine can be administered to poultry by mass application routes |
| 05/30/2002 | US20020064531 P28 gene family, may be involved in immune avoidance; DNA sequences, proteins, antibodies; use in vaccines against E. chaffeensis |
| 05/30/2002 | US20020064530 Variants of phleum pratense allergenic proteins |
| 05/30/2002 | US20020064527 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | US20020064521 Nucleic acids coding for both A and B chains of human p53, human leukocyte antigen(HLA) restricted murine T-cell receptor (TCR); transformed CD8+ cytotoxic T lymphocytes for immunotherapy of tumors that over-express p53 |
| 05/30/2002 | US20020064515 Administering synergistic mixtures of immunostimulatory CpG oligonucleotides with unmethylated cytosine and guanine in given sequence, and immunopotentiating cytokines; treating tumors; contraceptive |
| 05/30/2002 | US20020062835 Methods of modulating hair growth |
| 05/30/2002 | CA2429976A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2428885A1 Method of separating extra-chromosomal dna from other cellular components |
| 05/30/2002 | CA2427340A1 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
| 05/29/2002 | EP1209226A2 Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70) |
| 05/29/2002 | EP1208381A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208217A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
| 05/29/2002 | EP1208212A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| 05/29/2002 | EP1208206A2 Moraxella catarrhalis antigen basb121 |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208199A2 DNA CODING FOR $g(b)-TUBULIN AND USE THEREOF |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208115A2 Feline interleukin-12 as an immune stimulant |
| 05/29/2002 | EP1207906A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies |
| 05/29/2002 | EP1207905A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 05/29/2002 | EP1207904A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 05/29/2002 | EP1207899A2 Treatment of allergic rhinitis |
| 05/29/2002 | EP1207895A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 05/29/2002 | EP1207853A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 05/29/2002 | EP0938329B1 Immunogenic tlp composition |
| 05/29/2002 | EP0774974B1 Nucleic acid vaccine |
| 05/29/2002 | EP0665955B1 Particles having gelatin-aminodextran coatings of and processes for making same |
| 05/29/2002 | DE10055886A1 Impfstoffe, die rekombinante Hantavirusproteine enthalten, Verfahren zu iher Herstellung und ihre Verwendung Vaccines containing recombinant Hantavirusproteine, process for preparation and their use IHER |
| 05/29/2002 | CN1351714A Tandem immuno-assay for cancer |
| 05/29/2002 | CN1351713A Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 05/29/2002 | CN1351664A DNA sequence and recombination production of a graminae allergen |
| 05/29/2002 | CN1351663A Viral variants |
| 05/29/2002 | CN1351662A Inhibition of viral infection using monovalent antigen-binding proteins |
| 05/29/2002 | CN1351661A Compounds |
| 05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
| 05/29/2002 | CN1351502A Multivaleng dengue virus vaccine |
| 05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
| 05/29/2002 | CN1351500A Method for preparing dual virally inactivated immune globulin for intravenous administration |
| 05/29/2002 | CN1350871A Process for improving potency of pollen allergen vaccine |
| 05/28/2002 | US6395964 Oral immunization with transgenic plants |
| 05/28/2002 | US6395961 Gene transfer in chickens by introduction of DNA into muscle in ovo |
| 05/28/2002 | US6395882 Selectin ligands |
| 05/28/2002 | US6395876 High-affinity tryptophan transporter |
| 05/28/2002 | US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/28/2002 | US6395513 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/28/2002 | US6395512 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 05/28/2002 | US6395510 Vertebrate apoptosis gene: compositions and methods |
| 05/28/2002 | US6395498 Methods of identifying compounds that modulate body weight using the OB receptor |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395469 Inactivated respiratory syncytial viral vaccines |
| 05/28/2002 | US6395309 Use of an extract of Alchemilla vulgaris to inhibit angiogenesis |
| 05/28/2002 | US6395306 For rheumatoid arthritis |